Evidence map›Paper›PMID 38837060›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2024

Resolving spatial response heterogeneity in glioblastoma.

Julian Ziegenfeuter, Claire Delbridge, Denise Bernhardt, Jens Gempt, Friederike Schmidt-Graf, Dennis Hedderich, Michael Griessmair, Marie Thomas, Hanno S Meyer, Claus Zimmer and 5 more

Abstract read
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Julian ZiegenfeuterDepartment of Neuroradiology, School of Medicine and Health, Technical University of Munich, 81675, München, Germany. Julian@ziegenfeuter.de.ORCID 0000-0001-7306-7554
Claire DelbridgeDepartment of Pathology, Technical University of Munich, 81675, München, Germany.
Denise BernhardtDepartment of Radiation Oncology, School of Medicine and Health, Technical University of Munich, 81675, München, Germany.
Jens GemptDepartment of Neurosurgery, School of Medicine and Health, Technical University of Munich, 81675, München, Germany.
Friederike Schmidt-GrafDepartment of Neurology, School of Medicine and Health, Technical University of Munich, 81675, München, Germany.
Dennis HedderichDepartment of Neuroradiology, School of Medicine and Health, Technical University of Munich, 81675, München, Germany.
Michael GriessmairDepartment of Neuroradiology, School of Medicine and Health, Technical University of Munich, 81675, München, Germany.
Marie ThomasDepartment of Neuroradiology, School of Medicine and Health, Technical University of Munich, 81675, München, Germany.
Hanno S MeyerDepartment of Neurosurgery, School of Medicine and Health, Technical University of Munich, 81675, München, Germany.
Claus ZimmerDepartment of Neuroradiology, School of Medicine and Health, Technical University of Munich, 81675, München, Germany.
Bernhard MeyerDepartment of Neurosurgery, School of Medicine and Health, Technical University of Munich, 81675, München, Germany.
Stephanie E CombsDepartment of Radiation Oncology, School of Medicine and Health, Technical University of Munich, 81675, München, Germany.
Igor YakushevDepartment of Nuclear Medicine, School of Medicine and Health, Technical University of Munich, 81675, München, Germany.
Marie-Christin Metz *Department of Neuroradiology, School of Medicine and Health, Technical University of Munich, 81675, München, Germany.
Benedikt Wiestler *Department of Neuroradiology, School of Medicine and Health, Technical University of Munich, 81675, München, Germany.

Funding

Generalizable quantitative imaging and machine learning signatures in glioblastoma, for precision diagnostics and personalized treatment: the ReSPOND consortiumR01CA269948 · NCI · UNIVERSITY OF PENNSYLVANIA · PI Christos Davatzikos · 2022 to 2026
$3.2M
NCI NIH HHS R01 CA269948
6 · The paper itself

Abstract

purposeSpatial intratumoral heterogeneity poses a significant challenge for accurate response assessment in glioblastoma. Multimodal imaging coupled with advanced image analysis has the potential to unravel this response heterogeneity.

methodsBased on automated tumor segmentation and longitudinal registration with follow-up imaging, we categorized contrast-enhancing voxels of 61 patients with suspected recurrence of glioblastoma into either true tumor progression (TP) or pseudoprogression (PsP). To allow the unbiased analysis of semantically related image regions, adjacent voxels with similar values of cerebral blood volume (CBV), FET-PET, and contrast-enhanced T1w were automatically grouped into supervoxels. We then extracted first-order statistics as well as texture features from each supervoxel. With these features, a Random Forest classifier was trained and validated employing a 10-fold cross-validation scheme. For model evaluation, the area under the receiver operating curve, as well as classification performance metrics were calculated.

resultsOur image analysis pipeline enabled reliable spatial assessment of tumor response. The predictive model reached an accuracy of 80.0% and a macro-weighted AUC of 0.875, which takes class imbalance into account, in the hold-out samples from cross-validation on supervoxel level. Analysis of feature importances confirmed the significant role of FET-PET-derived features. Accordingly, TP- and PsP-labeled supervoxels differed significantly in their 10th and 90th percentile, as well as the median of tumor-to-background normalized FET-PET. However, CBV- and T1c-related features also relevantly contributed to the model's performance.

conclusionDisentangling the intratumoral heterogeneity in glioblastoma holds immense promise for advancing precise local response evaluation and thereby also informing more personalized and localized treatment strategies in the future.

Indexed as

Brain NeoplasmsGlioblastomaPositron-Emission TomographyAdultAgedFemaleHumansImage Processing, Computer-AssistedMagnetic Resonance ImagingMaleMiddle AgedDSC perfusionGlioblastomaPETPseudoprogressionRadiomicsSpatial heterogeneity

Identifiers

PMID38837060
PMCPMC11445274

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.